Teng Ji

1.0k total citations
29 papers, 642 citations indexed

About

Teng Ji is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Teng Ji has authored 29 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Teng Ji's work include Autoimmune Neurological Disorders and Treatments (3 papers), Virus-based gene therapy research (3 papers) and Cancer Mechanisms and Therapy (3 papers). Teng Ji is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (3 papers), Virus-based gene therapy research (3 papers) and Cancer Mechanisms and Therapy (3 papers). Teng Ji collaborates with scholars based in China, United States and Hong Kong. Teng Ji's co-authors include Qinglei Gao, Ding Ma, Zhiqiang Han, Jianfeng Zhou, Wei Xiao, Shixuan Wang, Suyue Pan, Hai‐Ying Shen, Zheng Dong and Wencheng Ding and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Teng Ji

28 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teng Ji China 16 347 190 99 87 86 29 642
Elena Cavadini Italy 19 669 1.9× 160 0.8× 163 1.6× 104 1.2× 103 1.2× 30 877
Jan Scicinski United States 16 425 1.2× 318 1.7× 120 1.2× 94 1.1× 145 1.7× 48 896
Qin Yu United States 13 393 1.1× 145 0.8× 145 1.5× 25 0.3× 69 0.8× 21 665
Gilda Raguénez France 18 614 1.8× 209 1.1× 150 1.5× 114 1.3× 135 1.6× 29 1.0k
Dongwei Zhang China 14 441 1.3× 181 1.0× 140 1.4× 34 0.4× 53 0.6× 35 654
Hongbo Wang China 16 471 1.4× 98 0.5× 229 2.3× 80 0.9× 103 1.2× 53 933
Joanna D. Stewart Germany 18 770 2.2× 128 0.7× 100 1.0× 62 0.7× 87 1.0× 27 1.1k
Linda K. Woods United States 7 353 1.0× 164 0.9× 104 1.1× 80 0.9× 71 0.8× 10 624
Evelyn Aranda United States 11 412 1.2× 210 1.1× 126 1.3× 80 0.9× 106 1.2× 12 753

Countries citing papers authored by Teng Ji

Since Specialization
Citations

This map shows the geographic impact of Teng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Ji more than expected).

Fields of papers citing papers by Teng Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Ji. The network helps show where Teng Ji may publish in the future.

Co-authorship network of co-authors of Teng Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Teng Ji. A scholar is included among the top collaborators of Teng Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Ji. Teng Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Teng, et al.. (2025). Ferroptosis enhances the therapeutic potential of oncolytic adenoviruses KD01 against cancer. Cancer Gene Therapy. 32(4). 403–417. 4 indexed citations
2.
Ji, Teng, et al.. (2024). Viral vector-based therapeutic HPV vaccines. Clinical and Experimental Medicine. 24(1). 199–199. 2 indexed citations
3.
Miao, Yan, Heng Cao, Bing Xiao, et al.. (2023). HDACs alters negatively to the tumor immune microenvironment in gynecologic cancers. Gene. 885. 147704–147704. 5 indexed citations
4.
5.
Xiao, Wei, Hua Lou, Dongchen Zhou, et al.. (2021). TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 292–292. 65 indexed citations
6.
Yu, Peng, Shanshan Pei, Zheng Dong, et al.. (2019). Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis. Frontiers in Immunology. 10. 905–905. 32 indexed citations
7.
Zhang, Zeyu, Xiaoting Li, Yingyan Han, et al.. (2019). RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. Biomedicine & Pharmacotherapy. 118. 109341–109341. 18 indexed citations
8.
Han, Yingyan, Peng Wu, Zhi Wang, et al.. (2019). Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation. EBioMedicine. 40. 92–105. 13 indexed citations
9.
Yu, Peng, Zheng Dong, Xiaomei Zhang, et al.. (2019). Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis. Frontiers in Immunology. 10. 103–103. 31 indexed citations
10.
Xiao, Wei, Rui Wei, Guiying Jiang, et al.. (2019). Mechanical Cues Modulate Cellular Uptake of Nanoparticles in Cancer Via Clathrin-Mediated and Caveolae-Mediated Endocytosis Pathways. Nanomedicine. 14(5). 613–626. 21 indexed citations
11.
Ding, Wencheng, et al.. (2018). Realgar, a traditional Chinese medicine, induces apoptosis of HPV16-positive cervical cells through a HPV16 E7-related pathway. Drug Design Development and Therapy. Volume 12. 3459–3469. 18 indexed citations
12.
Chen, Jinyu, Yuewen Ding, Zheng Dong, et al.. (2018). Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis. Frontiers in Neurology. 9. 727–727. 39 indexed citations
13.
Ding, Wencheng, Zheng Hu, Da Zhu, et al.. (2014). Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells. Clinical Cancer Research. 20(24). 6495–6503. 45 indexed citations
14.
Gao, Qinglei, Caihong Chen, Teng Ji, et al.. (2014). A Systematic Comparison of the Anti-Tumoural Activity and Toxicity of the Three Adv-TKs. PLoS ONE. 9(4). e94050–e94050. 8 indexed citations
15.
Ji, Teng, Danni Gong, Zhiqiang Han, et al.. (2013). Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer. Cancer Letters. 341(2). 231–239. 64 indexed citations
16.
Tian, Yuan, Wencheng Ding, Yingying Wang, et al.. (2013). Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters. PLoS ONE. 8(12). e84457–e84457. 16 indexed citations
17.
Han, Zhiqiang, Jing Feng, Zhenya Hong, et al.. (2013). Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. Biochemical and Biophysical Research Communications. 435(2). 188–194. 72 indexed citations
18.
Han, Zhiqiang, Zhenya Hong, Qinglei Gao, et al.. (2011). A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer. Human Gene Therapy. 23(1). 32–45. 23 indexed citations
19.
Ji, Teng & Kenneth J. Mack. (2009). Unilateral Chronic Daily Headache in Children. Headache The Journal of Head and Face Pain. 49(7). 1062–1065. 2 indexed citations
20.
Ji, Teng, Alexander Y. Zubkov, Eelco F. M. Wijdicks, et al.. (2008). Massive Tongue Swelling in Refractory Status Epilepticus Treated with High-Dose Pentobarbital. Neurocritical Care. 10(1). 73–75. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026